Antibiotic Based Articles & Analysis
6 news found
The second product is a Levofloxacin SR Ocular Implant, an antibiotic-based ocular implant, being developed as a treatment to reduce the risk of infection after cataract surgery. PolyActiva is based in Melbourne, Australia, and has secured venture capital funding from Brandon Capital’s Medical Research Commercialisation Fund (MRCF) and ...
The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance. ...
Ferring and Rebiotix, a Ferring Company, will present two oral abstracts describing translational studies of investigational microbiome-based therapeutics RBX2660 and RBX7455 for the treatment of recurrent Clostridioides difficile (C. diff) infection These data presentations strengthen the company’s leadership and scientific and clinical understanding of the two ...
Rebiotix and Ferring are the first to announce positive preliminary results on primary efficacy endpoint from ongoing pivotal Phase 3 clinical trial for RBX2660 RBX2660 is an investigational, non-antibiotic, microbiome-based therapy, developed to reduce Clostridioides difficile (C. diff) infection recurrences CDC defines C. diff as a major burden to patients ...
SEATTLE (March 29, 2017) Newly published, peer-reviewed results of observational clinical research have demonstrated that ID Genomics’ “bacterial fingerprinting” technology has the potential to improve antibiotic prescribing, reducing prescription errors and the overuse of broad-spectrum antibiotics, which could ultimately improve patient ...
ID Genomics is developing innovative “bacterial fingerprinting” technology that has the potential to reduce prescription errors and the overuse of broad-spectrum antibiotics by improving the accuracy and speed of antibiotic prescribing process. ...